ARCHIVES

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Task Force Reorganized, Foiled By Snow

March 2, 1979

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

March 26, 1976

Seven Seats Open Up On NCAB

January 17, 1986

NCI-Approved Clinical Trials

August 31, 2001

In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End

November 26, 1999

National Cancer Policy Forum Studies Modernization, Funding Of Cooperative Group Program.

July 11, 2008